Potential drug-drug and drug-disease interactions in well-functioning community-dwelling older adults

被引:48
作者
Hanlon, J. T. [1 ,2 ,3 ,4 ,5 ]
Perera, S. [1 ,6 ]
Newman, A. B. [1 ,3 ]
Thorpe, J. M. [2 ,4 ,5 ]
Donohue, J. M. [7 ]
Simonsick, E. M. [8 ]
Shorr, R. I. [9 ]
Bauer, D. C. [10 ]
Marcum, Z. A. [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Med, Div Geriatr, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA
[4] Vet Affairs Pittsburgh Healthcare Syst, Ctr Hlth Equ Res, Pittsburgh, PA USA
[5] Vet Affairs Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA
[6] Univ Pittsburgh, Dept Biostat, Sch Publ Hlth, Pittsburgh, PA 15261 USA
[7] Univ Pittsburgh, Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15260 USA
[8] NIA, Intramural Res Program, Baltimore, MD 21224 USA
[9] Malcolm Randall Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Gainesville, FL USA
[10] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
aged; drug interaction; drug utilization; INAPPROPRIATE MEDICATION USE; ELDERLY-PEOPLE; RISK; HEALTH; OUTPATIENTS;
D O I
10.1111/jcpt.12502
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
What is known and objective: There are few studies examining both drug-drug and drug-disease interactions in older adults. Therefore, the objective of this study was to describe the prevalence of potential drug-drug and drug-disease interactions and associated factors in community-dwelling older adults. Methods: This cross-sectional study included 3055 adults aged 70-79 without mobility limitations at their baseline visit in the Health Aging and Body Composition Study conducted in the communities of Pittsburgh PA and Memphis TN, USA. The outcome factors were potential drug-drug and drug-disease interactions as per the application of explicit criteria drawn from a number of sources to self-reported prescription and non-prescription medication use. Results: Over one-third of participants had at least one type of interaction. Approximately one quarter (25.1%) had evidence of had one or more drug-drug interactions. Nearly 10.7% of the participants had a drug-drug interaction that involved a non-prescription medication. % The most common drug-drug interaction was non-steroidal anti-inflammatory drugs (NSAIDs) affecting antihypertensives. Additionally, 16.0% had a potential drug-disease interaction with 3.7% participants having one involving non-prescription medications. The most common drug-disease interaction was aspirin/NSAID use in those with history of peptic ulcer disease without gastroprotection. Over one-third (34.0%) had at least one type of drug interaction. Each prescription medication increased the odds of having at least one type of drug interaction by 35-40% [drug-drug interaction adjusted odds ratio (AOR) = 1.35, 95% confidence interval (CI) = 1.27-1.42; drug-disease interaction AOR = 1.30; CI = 1.21-1.40; and both AOR = 1.45; CI = 1.34-1.57]. A prior hospitalization increased the odds of having at least one type of drug interaction by 49-84% compared with those not hospitalized (drug-drug interaction AOR = 1.49, 95% CI = 1.11-2.01; drug-disease interaction AOR = 1.69, CI = 1.15-2.49; and both AOR = 1.84, CI = 1.20-2.84). What is new and conclusionDrug interactions are common among community-dwelling older adults and are associated with the number of medications and hospitalization in the previous year. Longitudinal studies are needed to evaluate the impact of drug interactions on health-related outcomes.
引用
收藏
页码:228 / 233
页数:6
相关论文
共 27 条
  • [1] Explicit criteria for determining potentially inappropriate medication use by the elderly - An update
    Beers, MH
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (14) : 1531 - 1536
  • [2] Central nervous system medication use and incident mobility limitation in community elders: the health, aging, and body composition study
    Boudreau, Robert M.
    Hanlon, Joseph T.
    Roumani, Yazan F.
    Studenski, Stephanie A.
    Ruby, Christine M.
    Wright, Rollin M.
    Hilmer, Sarah N.
    Shorr, Ronald I.
    Bauer, Douglas C.
    Simonsick, Eleanor M.
    Newman, Anne B.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (10) : 916 - 922
  • [3] Inappropriate Medication Use as a Risk Factor for Self-Reported Adverse Drug Effects in Older Adults
    Chrischilles, Elizabeth A.
    VanGilder, Rachel
    Wright, Kara
    Kelly, Michael
    Wallace, Robert B.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 (06) : 1000 - 1006
  • [4] Bleeding Risk of Patients With Acute Venous Thromboembolism Taking Nonsteroidal Anti-Inflammatory Drugs or Aspirin
    Davidson, Bruce L.
    Verheijen, Sara
    Lensing, Anthonie W. A.
    Gebel, Martin
    Brighton, Timothy A.
    Lyons, Roger M.
    Rehm, Jeffrey
    Prins, Martin H.
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (06) : 947 - 953
  • [5] Drug-drug interactions related to hospital admissions in older adults: A prospective study of 1000 patients
    Doucet, J
    Chassagne, P
    Trivalle, C
    Landrin, I
    Pauty, MD
    Kadri, N
    Menard, JF
    Bercoff, E
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1996, 44 (08) : 944 - 948
  • [6] Clinical implications from drug-drug and drug-disease interactions in older people
    Gnjidic, Danijela
    Johnell, Kristina
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2013, 40 (05) : 320 - 325
  • [7] Goldstein H., 2011, MULTILEVEL STAT MODE
  • [8] GOSNEY M, 1984, LANCET, V2, P564
  • [9] Association of adverse drug reactions with drug-drug and drug-disease interactions in frail older outpatients
    Hanlon, Joseph T.
    Sloane, Richard J.
    Pieper, Carl F.
    Schmader, Kenneth E.
    [J]. AGE AND AGEING, 2011, 40 (02) : 274 - 277
  • [10] Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders
    Hanlon, JT
    Fillenbaum, GG
    Kuchibhatla, M
    Artz, MB
    Boult, C
    Gross, CR
    Garrard, J
    Schmader, KE
    [J]. MEDICAL CARE, 2002, 40 (02) : 166 - 176